RhumbLine Advisers’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.43M | Buy |
172,230
+6,907
| +4% | +$218K | ﹤0.01% | 1366 |
|
|
2025
Q1 | $5.41M | Sell |
165,323
-7,121
| -4% | -$233K | 0.01% | 1319 |
|
|
2024
Q4 | $6.24M | Buy |
172,444
+800
| +0.5% | +$28.9K | 0.01% | 1318 |
|
|
2024
Q3 | $5.35M | Sell |
171,644
-8,630
| -5% | -$269K | ﹤0.01% | 1392 |
|
|
2024
Q2 | $4.82M | Buy |
180,274
+5,813
| +3% | +$155K | ﹤0.01% | 1423 |
|
|
2024
Q1 | $5.95M | Sell |
174,461
-3,260
| -2% | -$111K | 0.01% | 1320 |
|
|
2023
Q4 | $5.14M | Buy |
177,721
+11,177
| +7% | +$323K | 0.01% | 1395 |
|
|
2023
Q3 | $4.59M | Buy |
166,544
+1,966
| +1% | +$54.2K | 0.01% | 1405 |
|
|
2023
Q2 | $4.95M | Sell |
164,578
-9,388
| -5% | -$282K | 0.01% | 1377 |
|
|
2023
Q1 | $6.3M | Buy |
173,966
+9,015
| +5% | +$327K | 0.01% | 1189 |
|
|
2022
Q4 | $5.88M | Buy |
164,951
+3,647
| +2% | +$130K | 0.01% | 1195 |
|
|
2022
Q3 | $5.46M | Buy |
161,304
+7,042
| +5% | +$238K | 0.01% | 1175 |
|
|
2022
Q2 | $4.46M | Buy |
154,262
+5,932
| +4% | +$172K | 0.01% | 1302 |
|
|
2022
Q1 | $4.79M | Buy |
148,330
+3,477
| +2% | +$112K | 0.01% | 1341 |
|
|
2021
Q4 | $4.22M | Sell |
144,853
-2,105
| -1% | -$61.4K | 0.01% | 1456 |
|
|
2021
Q3 | $3.92M | Sell |
146,958
-18,246
| -11% | -$487K | 0.01% | 1499 |
|
|
2021
Q2 | $5.09M | Sell |
165,204
-1,519
| -0.9% | -$46.8K | 0.01% | 1417 |
|
|
2021
Q1 | $4.37M | Buy |
166,723
+4,521
| +3% | +$118K | 0.01% | 1477 |
|
|
2020
Q4 | $4.08M | Buy |
162,202
+9,104
| +6% | +$229K | 0.01% | 1474 |
|
|
2020
Q3 | $3.19M | Sell |
153,098
-19,372
| -11% | -$404K | 0.01% | 1427 |
|
|
2020
Q2 | $4.1M | Buy |
172,470
+4,534
| +3% | +$108K | 0.01% | 1324 |
|
|
2020
Q1 | $3.02M | Buy |
167,936
+2,898
| +2% | +$52.1K | 0.01% | 1324 |
|
|
2019
Q4 | $3.92M | Buy |
165,038
+10,716
| +7% | +$254K | 0.01% | 1403 |
|
|
2019
Q3 | $4.24M | Buy |
154,322
+3,280
| +2% | +$90.1K | 0.01% | 1278 |
|
|
2019
Q2 | $5M | Buy |
151,042
+6,079
| +4% | +$201K | 0.01% | 1202 |
|
|
2019
Q1 | $5.08M | Buy |
144,963
+616
| +0.4% | +$21.6K | 0.01% | 1169 |
|
|
2018
Q4 | $4.8M | Buy |
144,347
+25,153
| +21% | +$836K | 0.01% | 1133 |
|
|
2018
Q3 | $6M | Sell |
119,194
-2,472
| -2% | -$124K | 0.01% | 990 |
|
|
2018
Q2 | $7.28M | Buy |
121,666
+4,248
| +4% | +$254K | 0.01% | 849 |
|
|
2018
Q1 | $5.38M | Buy |
117,418
+4,031
| +4% | +$185K | 0.01% | 993 |
|
|
2017
Q4 | $4.52M | Buy |
113,387
+16,630
| +17% | +$663K | 0.01% | 1128 |
|
|
2017
Q3 | $3.87M | Buy |
96,757
+2,850
| +3% | +$114K | 0.01% | 1200 |
|
|
2017
Q2 | $4.05M | Buy |
93,907
+288
| +0.3% | +$12.4K | 0.01% | 1128 |
|
|
2017
Q1 | $2.93M | Buy |
93,619
+28,420
| +44% | +$889K | 0.01% | 1332 |
|
|
2016
Q4 | $1.65M | Buy |
65,199
+4,151
| +7% | +$105K | ﹤0.01% | 1564 |
|
|
2016
Q3 | $1.51M | Buy |
61,048
+9,665
| +19% | +$239K | ﹤0.01% | 1583 |
|
|
2016
Q2 | $1.05M | Buy |
51,383
+11,485
| +29% | +$234K | ﹤0.01% | 1756 |
|
|
2016
Q1 | $608K | Buy |
39,898
+280
| +0.7% | +$4.27K | ﹤0.01% | 2088 |
|
|
2015
Q4 | $532K | Buy |
39,618
+4,000
| +11% | +$53.7K | ﹤0.01% | 2203 |
|
|
2015
Q3 | $500K | Buy |
35,618
+2,236
| +7% | +$31.4K | ﹤0.01% | 2223 |
|
|
2015
Q2 | $567K | Buy |
33,382
+6,040
| +22% | +$103K | ﹤0.01% | 2246 |
|
|
2015
Q1 | $331K | Buy |
27,342
+4,800
| +21% | +$58.1K | ﹤0.01% | 2552 |
|
|
2014
Q4 | $187K | Buy |
22,542
+700
| +3% | +$5.81K | ﹤0.01% | 2842 |
|
|
2014
Q3 | $190K | Hold |
21,842
| – | – | ﹤0.01% | 2784 |
|
|
2014
Q2 | $239K | Buy |
21,842
+9,540
| +78% | +$104K | ﹤0.01% | 2725 |
|
|
2014
Q1 | $110K | Sell |
12,302
-560
| -4% | -$5.01K | ﹤0.01% | 2910 |
|
|
2013
Q4 | $97K | Hold |
12,862
| – | – | ﹤0.01% | 2957 |
|
|
2013
Q3 | $94K | Sell |
12,862
-134
| -1% | -$979 | ﹤0.01% | 2938 |
|
|
2013
Q2 | $84K | Buy |
+12,996
| New | +$84K | ﹤0.01% | 3268 |
|